Ligand profile
MQ4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02854 — Putrescine aminotransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
MQ4- PDB
6oia- UniProt (similar protein)
P04181- Target protein
- KP13_02854
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 80.4
- −1 ≤ LogP ≤ 5 1.07
- MW ≤ 500 Da 237.2
- LogP ≤ 5 1.07
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 80.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1[C@@H](CC(=C1[C@@H](C=O)C(F)(F)F)N)C(=O)OC1[C@@H](CC(=C1[C@@H](C=O)C(F)(F)F)N)C(=O)O
InChI=1S/C9H10F3NO3/c10-9(11,12)6(3-14)5-1-4(8(15)16)2-7(5)13/h3-4,6H,1-2,13H2,(H,15,16)/t4-,6+/m0/s1InChI=1S/C9H10F3NO3/c10-9(11,12)6(3-14)5-1-4(8(15)16)2-7(5)13/h3-4,6H,1-2,13H2,(H,15,16)/t4-,6+/m0/s1
FRXHJQNUUVTCON-UJURSFKZSA-NFRXHJQNUUVTCON-UJURSFKZSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00202
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MQ4 →
- PDB RCSB structure 6oia →
- UniProt UniProt P04181 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MQ4”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02854.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).